21. Tyler Golato - VitaDAO, Longevity research & living to 1,000
"Longevity has the potential to be to traditional medicine what crypto is to traditional finance." Balaji Srinivasan, 2021 (@balajis).
Tyler Golato is co-founder of VitaDAO, which is shifting the paradigm on the science of ageing by prioritising research into preventative and pre-emptive medical in…
NFTs and the Art of Drug Development - Molecule
On this episode, our guest is economist Paul Kohlhaas, co-founder and CEO of Molecule and co-author of the VitaDAO whitepaper. We’ll head to Berlin, Germany, where Paul and his team of scientists, engineers, entrepreneurs and enthusiasts who are designing new ways to advance medicines. In Molecule’…
Emil Kendziorra, Tyler Golato, Paul Kolhaas, Ole Mensching | Longevity + Cryonics + Crypto
Why does signing up to cryonics today make sense? What are people not getting about longevity? And how can the crypto community and the longevity community work together?
All of these questions and more are being answered in this episode that was recorded live at the first ever Foresight gathering…
VitaDAO: NFTs for Longevity IP w/ the VITA Token - Interview with Tyler Golato, CSO of Molecule
In this interview, Greg Gillispie of Lifespan.io and Tyler Golato, co-founder and Chief Soience Officer of Molecule, discuss VitaDAO, a method of democratizing and decentralizing the development of longevity interventions with blockchain technology.
VitaDAO - Democratizing Longevity Research through the Blockchain (Tyler Golato and Laurence Ion)
On today’s episode of Translating Aging, Chris welcomes Tyler Golato and Laurence Ion to talk about VitaDAO, a collective accelerating research in human longevity and decentralized drug development. The pair start the conversation off by discussing their company’s roots - a previous business vent…
DeSci Ep #4: Decentralizing Drug Development—with Paul Kohlhaas & Tyler Golato of Molecule
Under the current centralized system, drug development happens in silos.
Pharmaceutical companies don’t share information. Scientists run the same failed experiments over and over again. And the process of bringing a drug to market typically takes ten-plus years.
But Paul Kohlhaas and Tyler G…
Episode 039 - Building a Stakeholder Co-Owned and Governed Pipeline of Novel Therapeutics: Tyler Golato on Molecule Protocol and Decentralized Science
In this episode of the Ownership Economy, we speak with Molecule Protocol’s Co-Founder and Chief Scientific Officer Tyler Golato. Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patient…
Bridging IP into Web3 with IP-NFTs
Tyler Golato is a Biogerontologist, and creative thinker building a more collaborative and open future. He co-founded Molecule and serves as Chief Scientist. He also co-initiated VitaDAO and PsyDAO and is focused on trying to develop new and innovative ways to improve funding processes in drug disc…
Talking DeSci with Molecule DAO - Ep. 9 - DeSci Collective Podcast
DeSci Collective hosted by Luke Szkudlarek features Tyler Golato from Molecule DAO and Brian Magierski from 21 Impact Labs to discuss their role in DeSci and highlight important DeSci milestones and developments.
Links
DeSci Collective Website - https://mintable.app/DeSciCollective
Discord Server …
The Incentives Structure in Research is Broken - with Tyler Golato, Molecule
In today's episode, we're diving into the groundbreaking intersection of intellectual property and blockchain technology with a focus on IP NFTs. Joining us is Tyler Golato, the co-founder and CEO of Molecule, a pioneering company revolutionizing biomedical innovation through NFTs.
Tyler shares Mo…
ポッドキャスト検索エンジン
当社の Web サイトを使用して、人、場所、トピックごとに 3,828,673 ポッドキャストや 196,489,583 エピソードを検索できます。
知識への投資は最も大きな利益をもたらす。だから私はポッドキャストを聴く。
‐ Benjamin "Llamacorn" Franklin
